Organogenesis Holdings Inc.ORGONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank89
3Y CAGR+3.9%
5Y CAGR+17.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+3.9%/yr
vs +38.7%/yr prior
5Y CAGR
+17.3%/yr
Recent deceleration
Acceleration
-34.8pp
Decelerating
Percentile
P89
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $44.54M | -11.4% |
| 2024 | $50.27M | +13.3% |
| 2023 | $44.38M | +11.6% |
| 2022 | $39.76M | +29.3% |
| 2021 | $30.74M | +53.1% |
| 2020 | $20.09M | +35.7% |
| 2019 | $14.80M | +37.8% |
| 2018 | $10.74M | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |